
Stereotaxis Inc (STXS) Stock Forecast & Price Target
Stereotaxis Inc (STXS) Analyst Ratings
Bulls say
Stereotaxis is a unique microcap company that is positioned for future growth due to developing tailwinds in system adoption and improved procedural utilization. The company has seen a delay in system sales, but expects to see growth in recurring revenue and catheter sales in the second half of 2021. While there are risks related to technology, IP, and the capital stack, STXS is making progress in its technology and has a strong outlook for future growth.
Bears say
Stereotaxis is a medical device company focused on developing advanced robotic solutions for minimally invasive endovascular procedures, with a core franchise in cardiac electrophysiology. Despite recent regulatory approvals, commercial traction for the company's products has been slow due to manufacturing constraints and low system placements. While there may be potential for growth in the future, current financials and operating results do not show immediate promise, and thus a negative outlook on Stereotaxis's stock is warranted.
This aggregate rating is based on analysts' research of Stereotaxis Inc and is not a guaranteed prediction by Public.com or investment advice.
Stereotaxis Inc (STXS) Analyst Forecast & Price Prediction
Start investing in Stereotaxis Inc (STXS)
Order type
Buy in
Order amount
Est. shares
0 shares